12-2677207-G-A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2
The NM_000719.7(CACNA1C):c.4942G>A(p.Ala1648Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000607 in 1,613,592 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000719.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1C | NM_000719.7 | c.4942G>A | p.Ala1648Thr | missense_variant | 40/47 | ENST00000399655.6 | NP_000710.5 | |
CACNA1C | NM_001167623.2 | c.4942G>A | p.Ala1648Thr | missense_variant | 40/47 | ENST00000399603.6 | NP_001161095.1 | |
CACNA1C-AS1 | NR_045725.1 | n.1024C>T | non_coding_transcript_exon_variant | 4/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399603.6 | c.4942G>A | p.Ala1648Thr | missense_variant | 40/47 | 5 | NM_001167623.2 | ENSP00000382512 | ||
CACNA1C | ENST00000399655.6 | c.4942G>A | p.Ala1648Thr | missense_variant | 40/47 | 1 | NM_000719.7 | ENSP00000382563 | ||
CACNA1C-AS1 | ENST00000501371.5 | n.985C>T | non_coding_transcript_exon_variant | 4/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152206Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000725 AC: 18AN: 248180Hom.: 0 AF XY: 0.0000891 AC XY: 12AN XY: 134708
GnomAD4 exome AF: 0.0000561 AC: 82AN: 1461386Hom.: 0 Cov.: 31 AF XY: 0.0000578 AC XY: 42AN XY: 726932
GnomAD4 genome AF: 0.000105 AC: 16AN: 152206Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74338
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 18, 2014 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2023 | CACNA1C: PP2 - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 24, 2024 | Reported in probands with a history of sudden death (PMID: 27930701, 30279520) and in patient referred for a suspected arrhythmogenic disorder (PMID: 31737537); also described as p.(A1696T) due to the use of an alternate transcript; In silico analysis supports that this missense variant does not alter protein structure/function; Published functional studies in HEK293 cells suggest that this variant causes a dramatic reduction in current density (PMID: 34999275); This variant is associated with the following publications: (PMID: 30279520, 31737537, 27930701, 34999275) - |
Timothy syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center For Human Genetics And Laboratory Diagnostics, Dr. Klein, Dr. Rost And Colleagues | Apr 13, 2017 | - - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 07, 2019 | The p.A1648T variant (also known as c.4942G>A), located in coding exon 40 of the CACNA1C gene, results from a G to A substitution at nucleotide position 4942. The alanine at codon 1648 is replaced by threonine, an amino acid with similar properties. This variant was detected in an individual with short-coupled torsades de pointes and in her daughter with ventricular fibrillation and short-coupled premature ventricular beats, as well as in the proband's unaffected brother (Blancard M et al. Sci Rep, 2018 Oct;8:14619). The variant was also reported (as c.5086G>A p.A1696T) in a sudden unexplained death case with limited clinical details provided (Sanchez O et al. PLoS ONE, 2016 Dec;11:e0167358). This amino acid position is well conserved in available vertebrate species; however, threonine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Long QT syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at